Cohance Lifesciences Limited (BOM:543064)
India
· Delayed Price · Currency is INR 949.95
+8.70 (0.92%)
At close: Aug 12, 2025
Cohance Lifesciences Revenue
In the fiscal year ending March 31, 2025, Cohance Lifesciences had annual revenue of 11.98B INR with 13.91% growth. Cohance Lifesciences had revenue of 4.02B in the quarter ending March 31, 2025, with 58.94% growth.
Revenue
11.98B
Revenue Growth
+13.91%
P/S Ratio
31.50
Revenue / Employee
10.04M
Employees
1,193
Market Cap
377.23B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |